Cart
sales@molnova.com
Nisoldipine
CAS No. 63675-72-9
Nisoldipine( BAY-k 5552 )
Catalog No. M15415 CAS No. 63675-72-9
A dihydropyridine type calcium channel blocker that is used as an antihypertensive.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 37 | In Stock |
|
| 500MG | 52 | In Stock |
|
| 1G | 85 | In Stock |
|
Biological Information
-
Product NameNisoldipine
-
NoteResearch use only, not for human use.
-
Brief DescriptionA dihydropyridine type calcium channel blocker that is used as an antihypertensive.
-
DescriptionA dihydropyridine type calcium channel blocker that is used as an antihypertensive.Hypertension Approved.
-
In Vitro——
-
In Vivo——
-
SynonymsBAY-k 5552
-
PathwayGPCR/G Protein
-
TargetCalcium Channel
-
RecptorL-typeCav1.2
-
Research AreaCardiovascular Disease
-
IndicationHypertension
Chemical Information
-
CAS Number63675-72-9
-
Formula Weight388.4144
-
Molecular FormulaC20H24N2O6
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
-
Chemical Name3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-, 3-methyl 5-(2-methylpropyl) ester
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Hamilton SF, et al. Heart Dis. 1999 Nov-Dec;1(5):279-88.
2. Duncker DJ, et al. Br J Pharmacol. 1986 May;88(1):9-18.
3. De Jong JW, et al. Br J Pharmacol. 1984 Dec;83(4):943-9.
molnova catalog
related products
-
JTV-519
JTV-519 (K201) is a Ca2+-dependent blocker of SERCA and a partial agonist of ryanodine receptors (RyRs).
-
Ticolubant
Ticolubant is orally active leukotriene B4 antagonist with high affinity for the human neutrophil LTB4 receptor (Ki = 0.78 nM), blocks LTB4-induced Ca2+ migration with an IC50 of 6.6 ± 1.5 nM, and shows topical anti-inflammatory activity in a mouse model of skin inflammation.
-
Oxodipine
Oxodipine, a dihydropyridine-type calcium antagonist, inhibited KCl-induced aortic contraction in rabbits and reduced cardiac force in less potent rat ventricular test-paper contractions.
